Compare and contrast yeast and fungi: Understand their cellular structure, modes of reproduction, and ecological roles.
Provide examples of superficial and systemic fungal infections: Identify fungal infections in clinical scenarios, differentiating between superficial (e.g., athlete's foot) and systemic infections (e.g., cryptococcosis).
Discuss opportunistic fungi, particularly Candida albicans and its role in thrush among AIDS patients: Examine how opportunistic fungi exploit weakened immune defenses in immunocompromised individuals.
Definitions
Mycology: Study of fungi, encompassing taxonomy, biology, and diseases they cause in humans.
Mycologists: Scientists specializing in fungi.
Mycoses: Diseases caused by fungal infections.
Etymology of terms: "mycosis" derives from Greek "mykos" (fungus) + "-osis" (condition or disease).
Fungi Characteristics
Species Diversity: Approx. 1.5 million known species, ~300 pathogenic to humans.
Environmental Importance: Essential for nutrient cycling, organic matter decomposition, and ecological relationships (e.g., mycorrhizae).
Eukaryotic Cells: Defined nucleus, phospholipid bilayer, contains ergosterol (target for antifungal medications).
Cell Wall: Primarily made of chitin and carbohydrates, providing structure and immune recognition.
Capsule: Antiphagocytic virulence factor aiding in immune evasion.
Types of Fungi:
Yeast: Unicellular, reproduce via budding; examples include Candida albicans.
Moulds (Filamentous Fungi): Multicellular with hyphae; engage in organic material degradation.
Dimorphic Fungi: Switch between yeast and mould forms (e.g., Histoplasma capsulatum).
Superficial Mycoses: Affect outer layers of skin, hair, nails (e.g., Tinea corporis, candidiasis).
Systemic Mycoses: Affect internal organs, can be life-threatening (e.g., histoplasmosis, cryptococcosis).
Invasive Fungal Infections: Opportunistic pathogens causing infections in immunocompromised individuals; notable examples include candidemia and disseminated candidiasis.
Increasing Cases: Rise in infections in patients undergoing chemotherapy and organ transplants.
Manageable Issues: Advances in diagnostics and antifungal treatments improve patient outcomes.
Methods:
Clinical observations of lesions and symptoms.
Laboratory tests including microscopic examination and culture.
Variable sampling based on infection site (skin scrapings, blood, sputum).